Company Filing History:
Years Active: 2015
Title: Michael P. Citron: Innovator in Respiratory Syncytial Virus Research
Introduction
Michael P. Citron is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of virology, particularly in the development of vaccines against respiratory syncytial virus (RSV). His work is crucial in addressing severe RSV-associated illnesses, which can have a profound impact on public health.
Latest Patents
Michael P. Citron holds a patent for a live, attenuated respiratory syncytial virus. This invention features live, attenuated RSV that is useful as a vaccine against RSV infection. The disclosed viruses are designed to be nonpathogenic when administered to a subject while retaining the antigenic and immunogenic properties of wild-type RSV. This innovation represents a significant advancement in vaccine development.
Career Highlights
Michael P. Citron is associated with Merck Sharp & Dohme Corp., a leading global healthcare company. His work at Merck has allowed him to focus on developing effective solutions for viral infections, contributing to the company's mission of improving health outcomes worldwide.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Mary K. Yagodich and Daniel J. Distefano. These collaborations have fostered a productive environment for innovation and research in the field of virology.
Conclusion
Michael P. Citron's contributions to the development of vaccines against respiratory syncytial virus highlight his commitment to advancing public health. His innovative work continues to pave the way for future research and development in virology.